Trial Profile
A randomised clinical trial on the effectiveness of Emla and Rapydan for prevention of vena punction-induced pain in children.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2012
Price :
$35
*
At a glance
- Drugs Lidocaine/prilocaine (Primary) ; Lidocaine/tetracaine (Primary)
- Indications Injection site pain
- Focus Therapeutic Use
- 12 Nov 2012 New trial record